M&A

Bristol-Myers teams with BioMotiv to build and buy biotechs
Fierce Biotech
Wed, 09/4/19 - 10:25 am
Bristol-Myers Squibb
BioMotiv
M&A
biotech
Rova-T: the story of AbbVie’s multi-billion dollar failure
Pharmaforum
Wed, 09/4/19 - 10:12 am
AbbVie
lung cancer
M&A
Stemcentrx
Rova-T
Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?
Endpoints
Tue, 09/3/19 - 10:56 am
Roche
Spark Therapeutics
FTC
CMA
M&A
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Stat
Tue, 09/3/19 - 10:32 am
Vertex Pharmaceuticals
M&A
diabetes
type 1 diabetes
Semma Therapeutics
Yes, Amgen overpaid for Otezla—but that doesn't make it a mistake: analysts
Fierce Pharma
Wed, 08/28/19 - 12:47 pm
Amgen
Otezla
Enbrel
drug reps
M&A
Celgene
Amgen puts out welcome mat for Celgene’s Otezla reps, but will they join—and then stay?
Fierce Pharma
Wed, 08/28/19 - 10:58 am
Amgen
Otezla
drug reps
M&A
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Stat
Mon, 08/26/19 - 10:24 am
Amgen
Otezla
Celgene
M&A
Bristol-Myers Squibb
psoriasis
From $30M launch round to $400M buyout deal — with $250M upfront — in 10 short months
Endpoints
Mon, 08/26/19 - 09:58 am
Modis
M&A
Zogenix
F-Prime
Should Amgen Finally Buy Alexion Pharmaceuticals?
Yahoo/Motley Fool
Sun, 08/25/19 - 05:00 pm
Amgen
Alexion
M&A
Why Alexion Makes Sense As A Target, But Amgen Doesn't As A Buyer
Investors Business Daily
Sat, 08/24/19 - 11:14 am
Amgen
Alexion
M&A
3 Reasons Why Amgen Could Actually Acquire Alexion
Motley Fool
Sat, 08/24/19 - 11:10 am
Alexion
Amgen
M&A
Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report
Investors Business Daily
Thu, 08/22/19 - 05:07 pm
Amgen
Alexion Pharmaceuticals
M&A
Could a 'creative deal' between Perrigo, Amneal help reinvent both struggling businesses?
Fierce Pharma
Wed, 08/21/19 - 10:50 am
Perrigo
Amneal
M&A
Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector
Endpoints
Tue, 08/20/19 - 12:46 pm
Elanco
Bayer
M&A
animal health
Celgene wins approval for drug key to Bristol buyout
Biopharma Dive
Fri, 08/16/19 - 01:06 pm
Celgene
FDA
Inrebic
myelofibrosis
M&A
Bristol-Myers Squibb
This Joint Is Jumping: PE Firms Knee-Deep In Orthopedic Space
Forbes
Fri, 08/16/19 - 10:11 am
devices
Orthopedics
M&A
private equity
Ultragenyx Inks a Partner-to-Buy Deal with GeneTx to Develop Treatment for Rare Genetic Syndrome
BioSpace
Thu, 08/15/19 - 12:20 pm
Ultragenyx
GeneTx Biotherapeutics
Angelman Syndrome
M&A
Allergan CEO Saunders lines up for $39M parachute after AbbVie buy
Fierce Pharma
Wed, 08/14/19 - 07:06 pm
Allergan
executive pay
Pharma CEOs
Brent Saunders
AbbVie
M&A
As investors fret about Xyrem durability, Jazz spends $52M+ upfront to swallow neuro-focused biotech
Endpoints
Wed, 08/14/19 - 10:19 am
Jazz Pharma
Xyrem
Cavion
M&A
Table for two: AbbVie was Allergan's only suitor in $63B takeover that shocked the industry
Fierce Pharma
Tue, 08/13/19 - 11:22 pm
AbbVie
Allergan
M&A

Pages